TLDR
- Bitcoin surged approximately 5% to reach $71,418, propelling crypto-related equities such as Strategy (+8%), Coinbase (+7%), and Riot Platforms (+4%) higher
- Moderna resolved a $950M patent conflict related to its COVID-19 vaccine, a figure below market concerns
- Ross Stores surpassed Q4 expectations and upgraded its outlook, sending shares soaring as much as 7.5%
- GitLab declined roughly 9% following a Q4 beat, undermined by disappointing full-year revenue projections
- Horizon Technology Finance tumbled 10% as total investment income of $20.7M fell short of the $23.9M forecast
Wednesday witnessed a substantial rebound in Bitcoin, which advanced roughly 5% to approximately $71,418. This upward momentum created a ripple effect throughout cryptocurrency-related equities.
Strategy posted an 8% increase, while Coinbase climbed approximately 7%, and MARA Holdings advanced 7%. Riot Platforms, Robinhood Markets, Galaxy Digital, and Hut 8 each registered gains ranging from 4% to 5%. Circle Internet Group similarly appreciated by 6%.
The cryptocurrency resurgence followed a downturn linked to escalating Middle East geopolitical concerns. Market participants appeared to rotate back into riskier asset classes as conditions normalized to some degree.
Precious metal mining companies also experienced gains Wednesday. Newmont advanced 2.8% while Freeport-McMoRan increased 1.9%, as Middle Eastern instability drove certain investors toward traditional safe-haven instruments like gold.
Moderna Resolves Patent Litigation for $950M
Moderna finalized a $950 million settlement agreement with Arbutus Biopharma and Genevant Sciences. The litigation centered on intellectual property disputes concerning its COVID-19 and RSV vaccine technologies.
Investors welcomed the settlement amount as favorable, having anticipated potentially steeper financial consequences. Moderna’s COVID-19 vaccine franchise has produced revenue ranging from $45 billion to $50 billion.
The settlement payment is scheduled for Q3 but will appear as a Q1 expense. Following this resolution, Moderna anticipates concluding the year with cash reserves between $4.5 billion and $5 billion.
Moderna intends to continue its appeal with the U.S. Federal Circuit. A positive outcome could eliminate any further financial obligation, while an unfavorable verdict might necessitate an additional $1.3 billion payment within 90 days.
Ross Stores experienced a robust session, climbing as much as 7.5% during premarket activity. The discount retailer exceeded Q4 projections and provided forward guidance significantly above analyst forecasts.
For Q1, Ross anticipates comparable sales expansion of 7% to 8%, substantially outpacing analyst predictions of roughly 3.7%. The retailer also announced a 10% dividend increase.
GitLab and Horizon Decline on Disappointing Forecasts
GitLab retreated between 8.5% and 9% notwithstanding its Q4 earnings outperformance. The software company’s annual revenue projection of $1.099 billion to $1.118 billion disappointed against the $1.13 billion consensus estimate.
CEO Bill Staples acknowledged dissatisfaction with the revenue outlook and presented a five-point plan to accelerate expansion.
Horizon Technology Finance plummeted 10% following disclosure of total investment income reaching $20.7 million, undershooting the $23.9 million projection. Net asset value per share also experienced modest deterioration during the period.
CrowdStrike inched up 1.1% after surpassing Q4 earnings and revenue benchmarks. Box appreciated 6.2% following its better-than-expected results and encouraging current-quarter guidance.
Broadcom traded 1% higher in anticipation of its fiscal first-quarter earnings release scheduled after market close, with analysts projecting its semiconductor division revenue to surge 51% year over year.
